Potential of BTK Inhibitors for Primary Progressive Multiple Sclerosis

Patricia K. Coyle, MD, a professor of neurology at Stony Brook Medicine, talked about the promising potential in ongoing studies assessing BTK inhibitors as treatment for primary progressive multiple sclerosis.

[mballer]

I detest videos that contain no talk of food intake, gut issues and lifestyle.
Use a placebo of excellent food precursors of myelin building and inflammation reduction.
MS is not uniform around the world, is it?
Is there a population with less MS? DO WHAT THEY DO.
(They're not taking your mystical drugs)